212 related articles for article (PubMed ID: 23715301)
21. Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer.
Miller KL; Marks LB; Sibley GS; Clough RW; Garst JL; Crawford J; Shafman TD
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):355-9. PubMed ID: 12738309
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial.
Tay RY; Fernández-Gutiérrez F; Foy V; Burns K; Pierce J; Morris K; Priest L; Tugwood J; Ashcroft L; Lindsay CR; Faivre-Finn C; Dive C; Blackhall F
Ann Oncol; 2019 Jul; 30(7):1114-1120. PubMed ID: 31020334
[TBL] [Abstract][Full Text] [Related]
23. [Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation
with Concurrent Twice-daily Radiotherapy for Patients
with Limited-stage Small Cell Lung Cancer].
You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):55-60. PubMed ID: 28103974
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
[TBL] [Abstract][Full Text] [Related]
25. Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer.
Ge XH; Lin Q; Ren XC; Liu YE; Chen XJ; Wang DY; Wang YQ; Cao B; Li ZG; Liu ML
Radiat Oncol; 2013 Oct; 8():238. PubMed ID: 24125485
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
[TBL] [Abstract][Full Text] [Related]
27. Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer.
Wahba HA; Halim AA; El-Hadaad HA
Med Oncol; 2012 Mar; 29(1):199-204. PubMed ID: 21140241
[TBL] [Abstract][Full Text] [Related]
28. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
[TBL] [Abstract][Full Text] [Related]
29. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study.
Sas-Korczyńska B; Łuczyńska E; Kamzol W; Sokołowski A
Strahlenther Onkol; 2017 Feb; 193(2):141-149. PubMed ID: 27785518
[TBL] [Abstract][Full Text] [Related]
30. Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer.
Choy H; Schwartzberg LS; Dakhil SR; Garon EB; Gerber DE; Choksi JK; Govindan R; Peng G; Koustenis A; Treat J; Obasaju C
J Thorac Oncol; 2013 Oct; 8(10):1308-16. PubMed ID: 23981966
[TBL] [Abstract][Full Text] [Related]
31. [Concurrent Chemoradiotherapy with Original Chemotherapy Regimens may not be Suitable for Patients Who Failed to Respond to Induction Chemotherapy
in Limited-stage Small Cell Lung Cancer].
Wang D; Xu L; Zhao L; Zhang W; Pang Q; Liu N; Chen X; Chen X; Yuan Z; Wang P
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):871-878. PubMed ID: 27978874
[TBL] [Abstract][Full Text] [Related]
32. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
33. Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.
Christodoulou M; Blackhall F; Mistry H; Leylek A; Knegjens J; Remouchamps V; Martel-Lafay I; Farré N; Zwitter M; Lerouge D; Pourel N; Janicot H; Scherpereel A; Tissing-Tan C; Peignaux K; Geets X; Konopa K; Faivre-Finn C
J Thorac Oncol; 2019 Jan; 14(1):63-71. PubMed ID: 30391573
[TBL] [Abstract][Full Text] [Related]
34. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated conformal radiotherapy in combination with chemotherapy in limited disease small cell lung cancer patients.
Socha J; Guzowska A; Tyc-Szczepaniak D; Szczęsna A; Kępka L
Pneumonol Alergol Pol; 2014; 82(2):105-15. PubMed ID: 24615194
[TBL] [Abstract][Full Text] [Related]
36. Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
Morimoto M; Okishio K; Akira M; Omachi N; Tamiya A; Asami K; Kawaguchi T; Atagi S
Clin Lung Cancer; 2017 Mar; 18(2):e117-e127. PubMed ID: 28340925
[TBL] [Abstract][Full Text] [Related]
37. Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer.
Gazula A; Baldini EH; Chen A; Kozono D
Lung; 2014 Feb; 192(1):151-8. PubMed ID: 24162870
[TBL] [Abstract][Full Text] [Related]
38. Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival.
Watkins JM; Wahlquist AE; Zauls AJ; Shirai K; Garrett-Mayer E; Aguero EG; Silvestri GA; Sherman CA; Sharma AK
J Med Imaging Radiat Oncol; 2010 Oct; 54(5):483-9. PubMed ID: 20958948
[TBL] [Abstract][Full Text] [Related]
39. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.
El Sharouni SY; Kal HB; Barten-Van Rijbroek A; Struikmans H; Battermann JJ; Schramel FM
Anticancer Res; 2009 Dec; 29(12):5219-24. PubMed ID: 20044639
[TBL] [Abstract][Full Text] [Related]
40. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]